BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 21709373)

  • 21. Angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers for diabetic nephropathy: a retrospective comparison.
    Robles NR; Romero B; Fernandez-Carbonero E; Sánchez-Casado E; Cubero JJ
    J Renin Angiotensin Aldosterone Syst; 2009 Dec; 10(4):195-200. PubMed ID: 20026868
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk of incident stroke in patients with Alzheimer disease or vascular dementia.
    Imfeld P; Bodmer M; Schuerch M; Jick SS; Meier CR
    Neurology; 2013 Sep; 81(10):910-9. PubMed ID: 23902701
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of ACE inhibitors and ARBs in hypertensive women of childbearing age.
    Martin U; Foreman MA; Travis JC; Casson D; Coleman JJ
    J Clin Pharm Ther; 2008 Oct; 33(5):507-11. PubMed ID: 18834365
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
    Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Usefulness of the alpha1-blocker doxazosin as a third-line antihypertensive drug.
    Ohta Y; Tsuchihashi T; Onaka U; Eto K; Ueno M
    Hypertens Res; 2007 Apr; 30(4):301-6. PubMed ID: 17541208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiotensin-converting enzyme inhibitor therapy and colorectal cancer risk.
    Makar GA; Holmes JH; Yang YX
    J Natl Cancer Inst; 2014 Feb; 106(2):djt374. PubMed ID: 24431411
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does use of antihypertensive drugs affect the incidence or progression of dementia? A systematic review.
    Shah K; Qureshi SU; Johnson M; Parikh N; Schulz PE; Kunik ME
    Am J Geriatr Pharmacother; 2009 Oct; 7(5):250-61. PubMed ID: 19948301
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retrospective analysis of real-world efficacy of angiotensin receptor blockers versus other classes of antihypertensive agents in blood pressure management.
    Petrella R; Michailidis P
    Clin Ther; 2011 Sep; 33(9):1190-203. PubMed ID: 21885126
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiotensin-receptor blockers and risk of Alzheimer's disease in hypertension population--a nationwide cohort study.
    Hsu CY; Huang CC; Chan WL; Huang PH; Chiang CH; Chen TJ; Chung CM; Lin SJ; Chen JW; Leu HB
    Circ J; 2013; 77(2):405-10. PubMed ID: 23149416
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antihypertensive treatment and risk of dementia: a retrospective database study.
    Wagner G; Icks A; Abholz HH; Schröder-Bernhardi D; Rathmann W; Kostev K
    Int J Clin Pharmacol Ther; 2012 Mar; 50(3):195-201. PubMed ID: 22373832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patterns of anti-inflammatory drug use and risk of dementia: a matched case-control study.
    Dregan A; Chowienczyk P; Armstrong D
    Eur J Neurol; 2015 Nov; 22(11):1421-8. PubMed ID: 26177125
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence and severity of gait disorders in Alzheimer's and non-Alzheimer's dementias.
    Allan LM; Ballard CG; Burn DJ; Kenny RA
    J Am Geriatr Soc; 2005 Oct; 53(10):1681-7. PubMed ID: 16181166
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324,168 participants from randomised trials.
    Bangalore S; Kumar S; Kjeldsen SE; Makani H; Grossman E; Wetterslev J; Gupta AK; Sever PS; Gluud C; Messerli FH
    Lancet Oncol; 2011 Jan; 12(1):65-82. PubMed ID: 21123111
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiotensin converting enzyme inhibitors impair recombinant human erythropoietin induced erythropoiesis in patients with chronic renal failure.
    Qureshi IZ; Abid K; Ambreen F; Qureshi AL
    Saudi Med J; 2007 Feb; 28(2):193-6. PubMed ID: 17268695
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Midlife risk factors for subtypes of dementia: a nested case-control study in Taiwan.
    Chiang CJ; Yip PK; Wu SC; Lu CS; Liou CW; Liu HC; Liu CK; Chu CH; Hwang CS; Sung SF; Hsu YD; Chen CC; Liu SI; Yan SH; Fong CS; Chang SF; You SL; Chen CJ
    Am J Geriatr Psychiatry; 2007 Sep; 15(9):762-71. PubMed ID: 17623813
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unspecified intestinal malabsorption in patients treated with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers: a retrospective analysis in primary care settings.
    De Bortoli N; Ripellino C; Cataldo N; Marchi S
    Expert Opin Drug Saf; 2017 Nov; 16(11):1221-1225. PubMed ID: 28871813
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of ACE inhibitors and angiotensin receptor blockers with keratinocyte cancer prevention in the randomized VATTC trial.
    Christian JB; Lapane KL; Hume AL; Eaton CB; Weinstock MA;
    J Natl Cancer Inst; 2008 Sep; 100(17):1223-32. PubMed ID: 18728281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subtypes of depression among patients with Alzheimer's disease and other dementias.
    Castilla-Puentes RC; Habeych ME
    Alzheimers Dement; 2010 Jan; 6(1):63-9. PubMed ID: 20129320
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between antihypertensive drug therapy and cognitive function in elderly hypertensive patients with memory complaints.
    Hanon O; Pequignot R; Seux ML; Lenoir H; Bune A; Rigaud AS; Forette F; Girerd X
    J Hypertens; 2006 Oct; 24(10):2101-7. PubMed ID: 16957572
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiotensin II type 1 receptor blockade: high hopes sent back to reality?
    Grothusen A; Divchev D; Luchtefeld M; Schieffer B
    Minerva Cardioangiol; 2009 Dec; 57(6):773-85. PubMed ID: 19942847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.